Treatment of erythema migrans in pregnancy

Clinical Infectious Diseases

Volumn 22, Issue 5, 1996, Pages 788-793

  Maraspin, V ^a   Cimperman, J ^a   Lotric Furlan S ^a   Pleterski Rigler, D ^a   Strle, F ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; PENICILLIN G; PENICILLIN V;

ADULT; ARTICLE; BORRELIA INFECTION; CONGENITAL HEART MALFORMATION; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MISSED ABORTION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL;

EID: 0030056216     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.5.788     Document Type: Article

References (49)

1. Stere AC, Bartenhagen NH, Craft JE, et al. Clinical manifestations of Lyme disease. Zentralbl Bakteriol Hyg A 1986;263:2015.
2. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96.
3. Schlesinger PA, Duray PH, Burke SA, Steere AC, Stillman MT. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985;103:67-8.
4. MacDonald AB. Human fetal borreliosis, toxemia of pregnancy and fetal death. Zentralbl Bakteriol Hyg A 1986;263:189-200.
5. MacDonald AB, Benach JL, Burgdorfer W. Stillbirth following maternal Lyme disease. N Y State J Med 1987;87:615-6.
6. Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988;7:286-9.
7. MacDonald AB. Gestational Lyme borreliosis: implications for the fetus. Rheum Dis Clin North Am 1989;15:657-77.
8. Hercogová J, Moidlová M, Živný J, Hulinská D, Rychterová V, Janovská D. Could borreliae found in the placenta influence the fetus? Study of 19 women with erythema migrans during pregnancy [abstract no PO06T]. In: Program and abstracts of the 6th International Conference on Lyme Borreliosis. Bologna, Italy: Societa Editrice Esculapio, 1994:76.
9. Lavoie PE, Lattner BP, Duray PH, Malawista SE, Barbour AG, Johnson RC. Culture positive, seronegative, transplacental Lyme borreliosis infant mortality [abstract no W/TH-P-92]. In: Abstracts (book B) of the 4th International Conference on Lyme Borreliosis. Stockholm, Sweden, 1990:128.
10. Markowitz LE, Steere AC, Benach JL, Slade JD, Broome CV. Lyme disease during pregnancy. JAMA 1986;255:3394-6.
11. Ciesielski CA, Russell H, Johnson S, Markowitz L, Benach J, Broome C. Prospective study of pregnancy outcomes in women with Lyme disease [abstract no 39]. In: Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy (New York). Washington, DC: American Society for Microbiology, 1987:103.
12. Strle F, Pejovnik-Pustinek A, Stanek G, Pleterski D, Rakar R. Lyme borreliosis in Slovenia in 1986. In: Stanek G, Kristoferitsch W, Pletchette M, Barbour AG, Flamm H, eds. Lyme borreliosis II. Stuttgart: Gustav Fischer Verlag, 1989:50-4.
13. Centers for Disease Control. Lyme disease surveillance - United States, 1989-1990. MMMR Morb Mortal Wkly Rep 1991;40:417-21.
14. Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister HW, Einhaupl K. Serological diagnosis of erythema migrans disease and related disorders. Infection 1984;12:331-7.
15. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of early manifestations of Lyme disease. Ann Intern Med 1983;99:22-6.
16. Taber LH, Feigin RD. Spirochetal infections. Pediatr Clin North Am 1979;26:377-413.
17. Lakos A. Lyme borreliosis and pregnancy [abstract no P11]. In: Symposium on the therapy and prophylaxis for Lyme borreliosis. Portorož, Slovenia: Austrian Society for Hygiene and Slovenian Society for Infectious Diseases, 1995:43.
18. Rahn DW, Malawista SE. Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med 1991;114:472-81.
19. Weber K, Neubert U, Thurmayr R. Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl Bakteriol Hyg A 1986;263:377-88.
20. Berger BV. Treatment of erythema chronicum migrans of Lyme disease. Ann NY Acad Sci 1988;539:346-51.
21. Weber K, Preac-Mursic V, Neubert U, et al. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann NY Acad Sci 1988;539:324-45.
22. Preac-Mursic V, Weber K, Pfister HW, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989;17:355-9.
23. Strle F, Preac-Mursic V, Cimperman J, Ružić E, Maraspin V, Jereb M. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 1993;21: 83-8.
24. Dattwyler RJ, Halperin JJ, Pass H, Luft BJ. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 1987;155: 1322-5.
25. Dattwyler RJ, Halperin JJ. Failure of tetracycline therapy in early Lyme disease. Arthritis Rheum 1987;30:448-50.
26. Preac-Mursic V, Wilske B, Schierz G, Pfister HW, Einhaupl KM. Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol 1984;4:564-5.
27. Maraspin V, Ružić-Sabljić E, Strle F, Cimperman J, Jereb M, Preac-Mursic V. Persistence of Borrelia burgdorferi after treatment with antibiotics. Alpe Adria Microbiol J 1995;3:211-6.
28. Liegner KB, Rosenkilde CE, Campbell GL, Quan TJ, Dennis DT. Culture confirmed treatment failure of cefotaxime and minocycline in a case of Lyme meningoencephalomyelitis in the United States [abstract no 63]. In: Program and abstracts of the 5th International Conference on Lyme Borreliosis. Arlington, Virginia: Federation of American Societies for Experimental Biology, 1992:A11.
29. Liegner KB, Shapiro RJ, Ramsay D, Halperin AJ, Hogrefe W, Kong L. Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection. J Am Acad Dermatol 1993;28:312-4.
30. Preac-Mursic V, Pfister HV, Spiegel H, et al. First isolation of Borrelia burgdorferi from an iris biopsy. J Clin Neuro-Ophthal 1993;13: 155-61.
31. Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP. Comparison of cefuroxime axetil and doxycycline in early Lyme disease. Ann Intern Med 1992;117:273-80.
32. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med 1992;92:396-403.
33. Strle F, Ružić E, Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J Antimicrob Chemother 1992;30:543-50.
34. Strle F, Ružić E, Cimperman J, Maraspin V, Lotrič S. Isolation of Borrelia burgdorferi from normal cerebrospinal fluid in seronegative patients with erythema migrans and peripheral facial palsy. Ann Rheum Dis 1993;52:411.
35. Strle F, Cheng Y, Cimperman J, et al. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions. Clin Infect Dis 1995;21:380-9.
36. Diringer MN, Halperin JJ, Dattwyler RJ. Lyme meningoencephalitis: report of a severe, penicillin resistant case. Arthritis Rheum 1987;30: 705-8.
37. Rahn DW. Lyme disease: clinical manifestations, diagnosis and treatment. Semin Arthritis Rheum 1991;20:201-18.
38. Weber K, Pfister HW. Clinical management of Lyme borreliosis. Lancet 1994;343:1017-20.
39. Sicuranza G, Baker DA. Lyme disease in pregnancy. In: Coyle PK, ed. Lyme disease. St. Louis: Mosby Year Book, 1993:184-6.
40. Ostrov BE, Athreya BH. Lyme disease. Difficulties in diagnosis and management. Pediatr Clin North Am 1991;38:535-53.
41. Cooke WD, Dattwyler RJ. Complications of Lyme borreliosis. Annu Rev Med 1992;43:93-103.
42. Christen HJ, Hanefeld F. Lyme borreliosis in childhood and pregnancy. In: Weber K, Burgdorfer W, eds. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993:228-39.
43. Huppertz HI. Childhood Lyme borreliosis in Europe. Eur J Pediatr 1990;149:814-21.
44. Inštitut za varovanje zdravja Republike Slovenije. Perinatalni informacijski sistem Slovenije. Primerjava podatkov med regijami za leta 1990-1994. Ljubljana, Slovenia: Inštitut za varovanje zdravja Republike Slovenije, 1994:t3-9.
45. Eriksen NL, Blanco DJ. Extended spectrum (second- and third-generation) cephalosporins. Obstet Gynecol Clin North Am 1989;19:461-74.
46. Moellering RC Jr. Principles of anti-infective therapy. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:199-212.
47. Inštitut za varovanje zdravja Republike Slovenije. Fetalne smrti v Sloveniji 1993. Primerjava podatkov med zdravstvenimi zavodi in regijami za leto 1993. Ljubljana, Slovenia: Inštitut za varovanje zdravja Republike Slovenije, 1994:t1-4.
48. Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992;42:378-83.
49. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993;17:708-17.